Cardiovascular events following vascular endothelial growth factor inhibitor therapy with sunitinib or pazopanib in patients with renal cell carcinoma - a nationwide registry-based follow-up study

被引：0
|
作者：
Shanmuganathan, J. [1 ]
Schou, M. S. Morten [2 ]
Butt, J. H. B. Jawad Haider [3 ]
Torp-Pedersen, C. T. P. Christian [3 ]
Poulsen, L. O. P. Laurids Ostergaard [1 ]
Pareek, M. P. Manan [3 ]
Gislason, G. G. Gunnar [3 ]
Kober, L. K. Lars [3 ]
Nielsen, D. N. Dorte [2 ]
El-Galaly, T. C. E. Tarec Christoffer [1 ]
Soegaard, P. S. Peter [1 ]
Mamas, M. A. M. Mamas A. [4 ]
Freeman, P. F. Phillip [1 ]
Kragholm, K. H. K. Kristian Hay [1 ]
机构：
[1] Aalborg Univ Hosp, Aalborg, Denmark
[2] Herlev Hosp, Dept Cardiol, Herlev, Denmark
[3] Copenhagen Univ Hosp, Dept Cardiol, Rigshosp, Copenhagen, Denmark
[4] Keele Univ, Cardiol, Keele, Staffs, England
来源：
EUROPEAN HEART JOURNAL | 2023年 / 44卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：2
相关论文
共 50 条
  • [21] The Impact of Cytoreductive Nephrectomy on Survival of Patients With Metastatic Renal Cell Carcinoma Receiving Vascular Endothelial Growth Factor Targeted Therapy
    Choueiri, Toni K.
    Xie, Wanling
    Kollmannsberger, Christian
    North, Scott
    Knox, Jennifer J.
    Lampard, J. Geoffrey
    McDermott, David F.
    Rini, Brian I.
    Heng, Daniel Y. C.
    JOURNAL OF UROLOGY, 2011, 185 (01): : 60 - 66
  • [22] The role of tumor vascular endothelial growth factor (VEGF) and vascular endothelial growth factor receptor (VEGFR) polymorphisms in the prediction of clinical outcome for patients with advanced renal cell carcinoma receiving first-line sunitinib.
    Bianconi, Maristella
    Scartozzi, Mario
    Faloppi, Luca
    Giampieri, Riccardo
    Maccaroni, Elena
    Bittoni, Alessandro
    Del Prete, Michela
    Loretelli, Cristian
    Belvederesi, Laura
    Conti, Alessandro
    Minardi, Daniele
    Burattini, Luciano
    Montironi, Rodolfo
    Cascinu, Stefano
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (05)
  • [23] Efficacy and Safety of Everolimus in Korean Patients with Metastatic Renal Cell Carcinoma Following Treatment Failure with a Vascular Endothelial Growth Factor Receptor-Tyrosine Kinase Inhibitor
    Park, Kwonoh
    Lee, Jae-Lyun
    Ahn, Jin-Hee
    Lee, Kyoo Hyung
    Jeong, In-Gab
    Song, Cheryn
    Hong, Bumsik
    Hong, Jun Hyuk
    Ahn, Hanjong
    CANCER RESEARCH AND TREATMENT, 2014, 46 (04): : 339 - 347
  • [24] Prognostic role of tumor necrosis, microvessel density, vascular endothelial growth factor and hypoxia inducible factor-1α in patients with clear cell renal carcinoma after radical nephrectomy in a long term follow-up
    Minardi, D.
    Lucarini, G.
    Filosa, A.
    Milanese, G.
    Zizzi, A.
    Di Primio, R.
    Montironi, R.
    Muzzonigro, G.
    INTERNATIONAL JOURNAL OF IMMUNOPATHOLOGY AND PHARMACOLOGY, 2008, 21 (02) : 447 - 455
  • [25] Vascular endothelial growth factor is associated with hepatocellular carcinoma recurrence, independent of folate and glutathione-related antioxidant enzymes: A follow-up study
    Hsiao, Yung-Fang
    Cheng, Shao-Bin
    Lai, Chia-Yu
    Liu, Hsiao-Tien
    Lin, Hui-Chen
    Huang, Yi-Chia
    NUTRITION RESEARCH, 2024, 128 : 70 - 81
  • [26] Quantification of tumour and circulating vascular endothelial growth factor (VEGF) in patients with oesophagogastric cancer: a long-term follow-up study
    Gray, R. T.
    O'Donnell, M. E.
    McGuigan, J. A.
    Spence, G. M.
    BRITISH JOURNAL OF BIOMEDICAL SCIENCE, 2012, 69 (02) : 71 - 75
  • [27] The impact of kidney function on the outcome of metastatic renal cell carcinoma patients treated with vascular endothelial growth factor-targeted therapy
    Macfarlane, Robyn
    Heng, Daniel Y. C.
    Xie, Wanling
    Knox, Jennifer J.
    McDermott, David F.
    Rini, Brian I.
    Kollmannsberger, Christian
    Choueiri, Toni K.
    CANCER, 2012, 118 (02) : 365 - 370
  • [28] Does Obesity Influence the Prognosis of Metastatic Renal Cell Carcinoma in Patients Treated with Vascular Endothelial Growth Factor-Targeted Therapy?
    Steffens, Sandra
    Gruenwald, Viktor
    Ringe, Kristina I.
    Seidel, Christoph
    Eggers, Hendrik
    Schrader, Mark
    Wacker, Frank
    Kuczyk, Markus A.
    Schrader, Andres J.
    ONCOLOGIST, 2011, 16 (11): : 1565 - 1571
  • [29] Clinical Outcome in Metastatic Renal Cell Carcinoma Patients After Failure of Initial Vascular Endothelial Growth Factor-Targeted Therapy
    Vickers, Michael M.
    Choueiri, Toni K.
    Rogers, Miranda
    Percy, Andrew
    Finch, Daygen
    Zama, Ivan
    Cheng, Tina
    North, Scott
    Knox, Jennifer J.
    Kollmannsberger, Christian
    McDermott, David F.
    Rini, Brian I.
    Heng, Daniel Y.
    UROLOGY, 2010, 76 (02) : 430 - 434
  • [30] DISEASES OF RENAL FUNCTION AND BONE METABOLISM IN LONG-TERM FOLLOW-UP FOLLOWING TREATMENT OF EARLY-ONSET CANCER. A REGISTRY-BASED STUDY.
    Gronroos, M.
    Liuhto, N.
    Malila, N.
    Madanat-Harjuoja, L.
    Matomaki, J.
    Lahteenmaki, P.
    PEDIATRIC BLOOD & CANCER, 2014, 61 : S195 - S196
12345